| Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology AB Benson, MI D’Angelica, DE Abbott, DA Anaya, R Anders, C Are, ... Journal of the National Comprehensive Cancer Network 19 (5), 541-565, 2021 | 625 | 2021 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 262 | 2023 |
| Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma AX Zhu, AR Abbas, MR de Galarreta, Y Guan, S Lu, H Koeppen, W Zhang, ... Nature medicine 28 (8), 1599-1611, 2022 | 242 | 2022 |
| FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors E Shi, J Chmielecki, CM Tang, K Wang, MC Heinrich, G Kang, CL Corless, ... Journal of translational medicine 14, 1-11, 2016 | 212 | 2016 |
| Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study S Qin, SL Chan, S Gu, Y Bai, Z Ren, X Lin, Z Chen, W Jia, Y Jin, Y Guo, ... The Lancet 402 (10408), 1133-1146, 2023 | 146 | 2023 |
| Molecular phylogeny of Pholadoidea Lamarck, 1809 supports a single origin for xylotrophy (wood feeding) and xylotrophic bacterial endosymbiosis in Bivalvia DL Distel, M Amin, A Burgoyne, E Linton, G Mamangkey, W Morrill, ... Molecular phylogenetics and evolution 61 (2), 245-254, 2011 | 115 | 2011 |
| Increased risk of additional cancers among patients with gastrointestinal stromal tumors: a population‐based study JD Murphy, GL Ma, JM Baumgartner, L Madlensky, AM Burgoyne, ... Cancer 121 (17), 2960-2967, 2015 | 90 | 2015 |
| Proteolytic cleavage of protein tyrosine phosphatase μ regulates glioblastoma cell migration AM Burgoyne, PJ Phillips-Mason, SM Burden-Gulley, S Robinson, ... Cancer research 69 (17), 6960-6968, 2009 | 77 | 2009 |
| PTPμ suppresses glioma cell migration and dispersal AM Burgoyne, JM Palomo, PJ Phillips-Mason, SM Burden-Gulley, ... Neuro-oncology 11 (6), 767-778, 2009 | 66 | 2009 |
| Single agent and synergistic activity of the “first-in-class” dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma AR Singh, S Joshi, AM Burgoyne, JK Sicklick, S Ikeda, Y Kono, JR Garlich, ... Molecular cancer therapeutics 15 (11), 2553-2562, 2016 | 59 | 2016 |
| CelAB, a multifunctional cellulase encoded by Teredinibacter turnerae T7902T, a culturable symbiont isolated from the wood-boring marine bivalve Lyrodus pedicellatus NA Ekborg, W Morrill, AM Burgoyne, L Li, DL Distel Applied and Environmental Microbiology 73 (23), 7785-7788, 2007 | 58 | 2007 |
| A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase μ SM Burden-Gulley, TJ Gates, AM Burgoyne, JL Cutter, DT Lodowski, ... Neoplasia 12 (4), 305-IN2, 2010 | 48 | 2010 |
| Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers R Okamura, R Kurzrock, RJ Mallory, PT Fanta, AM Burgoyne, BM Clary, ... International journal of cancer 148 (3), 702-712, 2021 | 46 | 2021 |
| NCCN guidelines® Insights: biliary tract cancers, version 2.2023: featured updates to the NCCN guidelines AB Benson, MI D’Angelica, T Abrams, DE Abbott, A Ahmed, DA Anaya, ... Journal of the National Comprehensive Cancer Network 21 (7), 694-704, 2023 | 43 | 2023 |
| Pathologic, molecular, and prognostic radiologic features of hepatocellular carcinoma KJ Fowler, A Burgoyne, TJ Fraum, M Hosseini, S Ichikawa, S Kim, A Kitao, ... Radiographics 41 (6), 1611-1631, 2021 | 43 | 2021 |
| Gastrointestinal stromal tumors in the setting of multiple tumor syndromes AM Burgoyne, N Somaiah, JK Sicklick Current opinion in oncology 26 (4), 408-414, 2014 | 38 | 2014 |
| Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression CM Tang, TE Lee, SA Syed, AM Burgoyne, SY Leonard, F Gao, JC Chan, ... Oncotarget 7 (48), 78226, 2016 | 37 | 2016 |
| Current management of succinate dehydrogenase–deficient gastrointestinal stromal tumors P Neppala, S Banerjee, PT Fanta, M Yerba, KA Porras, AM Burgoyne, ... Cancer and Metastasis Reviews 38, 525-535, 2019 | 36 | 2019 |
| Results from the MORPHEUS-liver study: Phase Ib/II randomized evaluation of tiragolumab (tira) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients with … RS Finn, BY Ryoo, CH Hsu, D Li, A Burgoyne, C Cotter, ... Journal of Clinical Oncology 41 (16_suppl), 4010-4010, 2023 | 32 | 2023 |
| Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis H Yoon, CM Tang, S Banerjee, M Yebra, S Noh, AM Burgoyne, JD Torre, ... Oncogene 40 (11), 1957-1973, 2021 | 32 | 2021 |
